ADMA Biologics, Inc. (ADMA) News
Follow ADMA Biologics, Inc. (ADMA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 22 public stories across 15 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
ADMA Biologics Shares Rise 25% After Higher Third-Quarter Results
ADMA Biologics reported third-quarter revenue of $141.1 million, compared with $134.2 million a year earlier. Its shares were up 25% at $13.06 in morning trading.
EARNINGS | Nov 05, 2026, 03:13 PM UTC
M
ADMA Biologics Reports Third-Quarter 2026 Financial Results
ADMA reported third-quarter 2026 revenue of $141.1 million, up 5% year over year. The supplied update also lists ASCENIV revenue of $12, with no unit or further context provided.
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
ADMA Biologics to Report Third-Quarter 2026 Results on November 4
EQUITY | Oct 28, 2026, 11:03 AM UTC
L
Ten healthcare stocks with A-rated valuations and strong revenue growth
Healthcare stocks remain a focal point for investors as pharmaceutical innovation, biotechnology advancements, and managed care expansion continue to drive growth across the sector.While many healthcare companies trade a
EQUITY | Sep 09, 2026, 03:01 PM UTC
L
ADMA Biologics Affirms FY2026 Sales Guidance of $530.000M-$560.000M vs $559.495M Est
ADMA Biologics (NASDAQ: ADMA ) affirms FY2026 sales outlook from $530.000 million-$560.000 million to $530.000 million-$560.000 million vs $559.495 million estimate.
EARNINGS | Aug 05, 2026, 08:24 PM UTC
L
ADMA - ADMA Biologics Reports Second Quarter 2026 Financial Results and Provides Business Update
ADMA - ADMA Biologics Reports Second Quarter 2026 Financial Results and Provides Business Update
EARNINGS | Aug 05, 2026, 08:05 PM UTC
H
ADMA Biologics Faces Securities Fraud Class Action
ADMA stock drops 29% on channel stuffing allegations
EQUITY | Aug 04, 2026, 10:36 AM UTC
L
ADMA Faces Securities Fraud Class Action
ADMA investors advised to inquire about securities fraud class action
EQUITY | Aug 03, 2026, 01:54 PM UTC
H
ADMA Biologics Sued
ADMA Biologics faces securities law violations lawsuit
EQUITY | Jul 31, 2026, 06:52 AM UTC
L
ADMA: Lawsuit Lead Plaintiff Deadline August 10
ADMA lawsuit lead plaintiff deadline nears
FX | Jul 30, 2026, 02:07 PM UTC
L
ADMA - ADMA Biologics to Report Second Quarter 2026 Financial Results on August 5, 2026
ADMA - ADMA Biologics to Report Second Quarter 2026 Financial Results on August 5, 2026
EARNINGS | Jul 29, 2026, 11:01 AM UTC
L
ADMA - ADMA Class Reminder: ADMA Biologics Investors are Reminded of the Upcoming August 10 Deadline in the Filed Securities Fraud Class Act
ADMA - ADMA Class Reminder: ADMA Biologics Investors are Reminded of the Upcoming August 10 Deadline in the Filed Securities Fraud Class Action to Recover Losses
EQUITY | Jul 28, 2026, 10:37 AM UTC
L
ADMA - ADMA Alert: ADMA Biologics, Inc. (NASDAQ: ADMA) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed - Click
ADMA - ADMA Alert: ADMA Biologics, Inc. (NASDAQ: ADMA) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed
EQUITY | Jul 27, 2026, 01:30 PM UTC
L
ADMA Investor Alert: ADMA Biologics Investors Notified of the Important August 10 Deadline in Filed Securities Fraud Class Action Lawsuit
A securities fraud class action lawsuit has been filed on behalf of ADMA Biologics investors after its stock plummeted 29% due to Culper Research channel stuffing claims, potentially violating f
REGULATION | Jul 05, 2026, 11:11 AM UTC
L
$ADMA Stock Loss Notice: ADMA Biologics Investors That Lost Money When Stock Plummeted 29% May Have Rights in Securities Fraud Class Action
NEW YORK CITY, NY / / July 4, 2026 / Leading securities law firm
EQUITY | Jul 04, 2026, 10:19 AM UTC
L
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class
New York, New York--(. - July 3, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ADMA Biologics, Inc. (NASDAQ: ADMA) between August 9
EQUITY | Jul 03, 2026, 09:18 PM UTC
L
Levi & Korsinsky Urges ADMA Biologics, Inc. (ADMA) Shareholders to Act Before Lead Plaintiff Deadline August 10, 2026
NEW YORK, NY / / July 3, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has b
EQUITY | Jul 03, 2026, 09:15 PM UTC
L
ADMA Court Reminder: ADMA Biologics Investors are Notified to Act before the Upcoming Securities Fraud Class Action Deadline on August 10
A securities fraud class action lawsuit has been filed on behalf of ADMA Biologics investors after its stock plummeted 29% due to Culper Research channel stuffing claims, potentially violating f
EQUITY | Jul 03, 2026, 07:19 PM UTC
L
Levi & Korsinsky Notifies ADMA Biologics, Inc. (ADMA) Investors - Lead Plaintiff Deadline on August 10, 2026
NEW YORK CITY, NY / / July 3, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit
EQUITY | Jul 03, 2026, 12:35 PM UTC
L
ROSEN, SKILLED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class A
NEW YORK CITY, NY / / July 3, 2026 / WHY: Rosen Law Firm, a global investor rights law firm, re
EQUITY | Jul 03, 2026, 12:00 PM UTC
L
ADMA Biologics, Inc. (ADMA) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before August 10, 2026
NEW YORK CITY, NY / / July 3, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit
EQUITY | Jul 03, 2026, 04:15 AM UTC
L
Join Class Action to Recover Losses from ADMA Biologics, Inc. (ADMA) - Contact Levi & Korsinsky Before August 10, 2026
NEW YORK CITY, NY / / July 2, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit
EQUITY | Jul 03, 2026, 01:45 AM UTC